Acquisition by Michael Alfieri of 2500 shares of Aldeyra at 5.3 subject to Rule 16b-3
| ALDX Stock | USD 4.95 0.25 5.32% |
Slightly above 66 percent of all Aldeyra's investors are curious in acquiring. The analysis of the overall investor sentiment regarding Aldeyra suggests that a large number of traders are confidant. Aldeyra's investing sentiment can be driven by a variety of factors including economic data, Aldeyra's earnings reports, geopolitical events, and overall market trends.
Filed transaction by Aldeyra Officer: Principal Financial Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at news.google.com
![]() |
Aldeyra Current Investor Sentiment
Comfort Level 66
Interested
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Aldeyra's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Aldeyra.
News SentimentBullish | Hype SentimentBullish | Insider SentimentDisposing |
Aldeyra Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Aldeyra can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Alkermes appoints new CFO
recently @ seekingalpha.com
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Aldeyra Historical Investor Sentiment
Investor biases related to Aldeyra's public news can be used to forecast risks associated with an investment in Aldeyra. The trend in average sentiment can be used to explain how an investor holding Aldeyra can time the market purely based on public headlines and social activities around Aldeyra. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Aldeyra's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Aldeyra and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Aldeyra news discussions. The higher the estimate score, the more favorable the investor's outlook on Aldeyra.
Aldeyra Maximum Pain Price Across January 16th 2026 Option Contracts
Aldeyra's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Aldeyra close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Aldeyra's options.
Aldeyra Fundamental Analysis
We analyze Aldeyra's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aldeyra using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aldeyra based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
Aldeyra is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Aldeyra Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aldeyra stock to make a market-neutral strategy. Peer analysis of Aldeyra could also be used in its relative valuation, which is a method of valuing Aldeyra by comparing valuation metrics with similar companies.
Peers
Aldeyra Related Equities
| CTNM | Contineum Therapeutics, | 10.96 | ||||
| KYTX | Kyverna Therapeutics, | 6.03 | ||||
| MREO | Mereo BioPharma | 3.40 | ||||
| ANRO | Alto Neuroscience, | 3.05 | ||||
| CADL | Candel Therapeutics | 1.33 | ||||
| GNLX | Genelux Common | 0.22 | ||||
| ACIU | AC Immune | 0.71 | ||||
| SLN | Silence Therapeutics | 0.72 | ||||
| CLLS | Cellectis | 2.53 | ||||
| AMRN | Amarin PLC | 9.79 |
Additional Tools for Aldeyra Stock Analysis
When running Aldeyra's price analysis, check to measure Aldeyra's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aldeyra is operating at the current time. Most of Aldeyra's value examination focuses on studying past and present price action to predict the probability of Aldeyra's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aldeyra's price. Additionally, you may evaluate how the addition of Aldeyra to your portfolios can decrease your overall portfolio volatility.
